Kim Sooyoung, Jeong Seong Ho, Shin Ha Young, Kim Seung Woo
Department of Neurology, Chungnam National University Hospital, Daejeon, South Korea.
Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea.
Front Neurol. 2022 Aug 5;13:847873. doi: 10.3389/fneur.2022.847873. eCollection 2022.
To investigate the intention of coronavirus disease 2019 (COVID-19) vaccination in Korean patients with myasthenia gravis (MG) and to determine the factors that influence their attitude toward COVID-19 vaccination.
We conducted a questionnaire survey of 160 Korean patients with MG. The questionnaire consisted of five categories, including vaccination status, willingness to get vaccinated, general concerns over vaccination, impact of MG diagnosis on vaccination decision, and MG-specific concerns over vaccination. The responses were rated from 1 (no intention or influence) to 5 (significant intention or influence). We compared the clinical factors between patients willing to get vaccinated (willing group) and those who were neutral or unwilling (hesitant group).
The average score of willingness to get vaccinated was 4.1 ± 1.2 (Likert score, 1-5). The hesitant group demonstrated higher proportions of women, patients with MG Foundation of America (MGFA) classification ≥III at nadir, and those who had experienced myasthenic crisis than the willing group (women, = 0.027; MGFA classification≥III, = 0.018; myasthenic crisis, = 0.027). Scores for the willingness to get vaccinated (Likert score, 1-5) were negatively correlated with the MGFA classification at nadir ( = -0.235, = 0.003), degree of general concern about vaccination ( = -0.362, < 0.001), and impact of MG diagnosis on vaccination decision ( = -0.365, < 0.001). In the path analysis, the MGFA classification at nadir was negatively associated with the willingness to get vaccinated by increasing the impact of MG diagnosis on vaccination decision.
MG diagnosis, maximum disease severity, and general concerns about vaccination influenced the intention to get vaccinated.
调查韩国重症肌无力(MG)患者对2019冠状病毒病(COVID-19)疫苗接种的意愿,并确定影响其对COVID-19疫苗接种态度的因素。
我们对160名韩国MG患者进行了问卷调查。问卷包括五个类别,包括疫苗接种状况、接种意愿、对疫苗接种的总体担忧、MG诊断对疫苗接种决策的影响以及对疫苗接种的MG特异性担忧。回答从1分(无意愿或影响)到5分(强烈意愿或影响)进行评分。我们比较了愿意接种疫苗的患者(意愿组)和中立或不愿意接种的患者(犹豫组)之间的临床因素。
接种意愿的平均得分为4.1±1.2(李克特评分,1-5)。与意愿组相比,犹豫组中女性、美国重症肌无力基金会(MGFA)最低分类≥III级的患者以及经历过肌无力危象的患者比例更高(女性,P=0.027;MGFA分类≥III级,P=0.018;肌无力危象,P=0.027)。接种意愿得分(李克特评分,1-5)与最低MGFA分类呈负相关(P=-0.235,P=0.003),与对疫苗接种的总体担忧程度呈负相关(P=-0.362,P<0.001),与MG诊断对疫苗接种决策的影响呈负相关(P=-0.365,P<0.001)。在路径分析中,最低MGFA分类通过增加MG诊断对疫苗接种决策的影响与接种意愿呈负相关。
MG诊断、最大疾病严重程度以及对疫苗接种的总体担忧影响了接种意愿。